Netris Pharma
PrivateLast Round
Grant
May 28, 2026
Total Funding Raised
$48.64M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Netris Pharma is a biotechnology company that develops anti-cancer therapeutic molecules designed to overcome resistance to oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Netris Pharma Comparables
Compare Netris Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medannex Ltd | 81% | |
| Compugen Ltd. | 78% | |
| Alethia Biotherapeutics | 77% | |
Netris Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2026 | ||||
| Series A Extension | Dec 19, 2023 | ||||
| Grant | Jan 19, 2023 | ||||
| Grant | Dec 16, 2021 | ||||
| Series A | Dec 23, 2020 |
Netris Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Eclosion Ventures | Series A |
| Eurostars SME programme | Grant |
| Wille Finance AG | Series A |
| Horizon Europe | Grant |
| Bpifrance | Series A |
| EIC Fund | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 33% MoM.
Netris Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Netris Pharma's valuation, stock price, and market status.